|
🐜
|
COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
48 auth.
A. Shields,
S. Burns,
S. Savic,
A. Richter,
A. Anantharachagan,
G. Arumugakani,
K. Baker,
S. Bahal,
W. Bermingham,
Malini V. Bhole,
E. Boules,
P. Bright,
S. Burns,
Betsy Cleave,
J. Dempster,
...
L. Devlin,
Fatima Dhalla,
E. Drewe,
C. Duncan,
M. Dziadzio,
S. Elkhalifa,
A. Gennery,
S. Goddard,
S. Grigoriadou,
G. Hayman,
A. Herwadkar,
A. Huissoon,
R. Jain,
S. Jolles,
S. Johnston,
L. Leeman,
S. Mahabir,
D. MacLochlainn,
E. McDermott,
S. Misbah,
H. Morsi,
S. Murng,
S. Noorani,
R. O’Brien,
Smita Y. Patel,
A. Price,
A. Richter,
S. Seneviratne,
A. Shields,
A. Shrimpton,
C. Stroud,
P. Vaitla,
N. Verma
|
7 |
2020 |
7
🐜
|
|
🐜
|
The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008–2012
50 auth.
J. Edgar,
M. Buckland,
D. Guzman,
Niall Conlon,
V. Knerr,
C. Bangs,
V. Reiser,
Z. Panahloo,
S. Workman,
M. Slatter,
A. Gennery,
E. Davies,
Z. Allwood,
P. Arkwright,
M. Helbert,
...
H. Longhurst,
S. Grigoriadou,
L. Devlin,
A. Huissoon,
M. Krishna,
S. Hackett,
D. Kumararatne,
Alison M. Condliffe,
H. Baxendale,
Katherine L. Henderson,
C. Bethune,
C. Symons,
P. Wood,
K. Ford,
Smita Y. Patel,
R. Jain,
S. Jolles,
T. El-shanawany,
H. Alachkar,
A. Herwadkar,
R. Sargur,
A. Shrimpton,
G. Hayman,
M. Abuzakouk,
G. Spickett,
C. Darroch,
S. Paulus,
S. Marshall,
E. McDermott,
P. Heath,
R. Herriot,
S. Noorani,
M. Turner,
Sujoy Khan,
B. Grimbacher
|
6 |
2014 |
6
🐜
|
|
🐬
|
ESPGHAN Guidance on Coeliac Disease 2012: Multiples of ULN for Decision Making Do Not Harmonise Assay Performance Across Centres
W. Egner,
A. Shrimpton,
R. Sargur,
D. Patel,
K. Swallow
|
5 |
2012 |
5
🐬
|
|
🐢
|
What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review
Georgina L Jones,
K. Vogt,
D. Chambers,
M. Clowes,
A. Shrimpton
|
4 |
2018 |
4
🐢
|
|
🐬
|
A 17‐year experience in perioperative anaphylaxis 1998–2015: harmonizing optimal detection of mast cell mediator release
William Egner,
R. Sargur,
A. Shrimpton,
M. York,
K. Green
|
4 |
2016 |
4
🐬
|
|
🐜
|
Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay
7 auth.
R. Sargur,
D. Cowley,
S. Murng,
Graeme Wild,
K. Green,
A. Shrimpton,
...
William Egner
|
4 |
2011 |
4
🐜
|
|
🐜
|
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
62 auth.
A. Shields,
A. Anantharachagan,
G. Arumugakani,
K. Baker,
S. Bahal,
H. Baxendale,
W. Bermingham,
Malini V. Bhole,
E. Boules,
P. Bright,
C. Chopra,
L. Cliffe,
Betsy Cleave,
J. Dempster,
L. Devlin,
...
Fatima Dhalla,
L. Diwakar,
E. Drewe,
C. Duncan,
M. Dziadzio,
Suzanne E. Elcombe,
S. Elkhalifa,
A. Gennery,
Harichandrana Ghanta,
S. Goddard,
S. Grigoriadou,
S. Hackett,
G. Hayman,
R. Herriot,
A. Herwadkar,
A. Huissoon,
R. Jain,
S. Jolles,
S. Johnston,
Sujoy Khan,
J. Laffan,
P. Lane,
L. Leeman,
D. Lowe,
S. Mahabir,
D. J. M. Lochlainn,
E. McDermott,
S. Misbah,
F. Moghaddas,
H. Morsi,
S. Murng,
S. Noorani,
R. O’Brien,
Smita Y. Patel,
A. Price,
Tasneem Rahman,
S. Seneviratne,
A. Shrimpton,
C. Stroud,
Moira J. Thomas,
K. Townsend,
P. Vaitla,
N. Verma,
Anthony E. Williams,
S. Burns,
S. Savic,
A. Richter
|
4 |
2022 |
4
🐜
|
|
🐬
|
Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease.
J. Malkin,
A. Shrimpton,
M. Wiselka,
M. Barer,
M. Duddridge,
N. Perera
|
4 |
2009 |
4
🐬
|
